SCHEMBL6981258

SCHEMBL6981258

O=S(=O)(Nc1ccc(F)cc1)c1ccc(CO)c(Cl)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B3 P37058 1/20 0.57
HSD17B2 P37059 1/20 0.57
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
POLB P06746 2/20 0.49
MIF P14174 1/20 0.48
ALDH1A1 P00352 4/20 0.47
CYP2C9 P11712 3/20 0.47
CYP2C19 P33261 2/20 0.47
LMNA P02545 1/20 0.47
MAPT P10636 1/20 0.47
CYP2C8 P10632 1/20 0.47
SLC22A6 Q4U2R8 1/20 0.47
SLC22A8 Q8TCC7 1/20 0.47
SLC22A12 Q96S37 1/20 0.47
SLC22A11 Q9NSA0 1/20 0.47
MAPK1 P28482 2/20 0.47
CYP3A4 P08684 2/20 0.47
METAP2 P50579 1/20 0.46
MEN1 O00255 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6981946 0.92 HSD17B3 (0.68) HSD17B3HSD17B2CA1CA2POLB
SCHEMBL6981251 0.86 HSD17B3 (0.53) HSD17B3HSD17B2CA1CA2POLB
SCHEMBL14610764 0.78 CCR2 (0.62) CYP2C9CYP2C19CYP3A4METAP2MEN1
SCHEMBL6979125 0.78 HSD17B3 (0.64) HSD17B3HSD17B2CA1CA2POLB
SCHEMBL2888624 0.78 HSD17B3 (0.53) HSD17B3HSD17B2CA1CA2POLB
SCHEMBL6980613 0.76 FFAR1 (0.64) HSD17B3HSD17B2CA1CA2POLB
SCHEMBL6977018 0.75 ALDH1A1 (0.60) HSD17B3HSD17B2POLBALDH1A1LMNA
SCHEMBL6976969 0.75 LMNA (0.57) HSD17B3HSD17B2POLBMIFALDH1A1
SCHEMBL7501950 0.75 CA1 (0.81) HSD17B3HSD17B2CA1CA2POLB
SCHEMBL3366221 0.74 CES1 (0.81) HSD17B3HSD17B2CA1CA2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1109560-B1 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMA (US) 2003-08-27 EP disclosed
US-6525050-B1 Inhibit the enzyme aminoimidazole carboxamide ribonucleotide formyl transferase; antiproliferative agents; antitumor, antiinflammatory, antipsoriatic, and/or immunosuppressive AGOURON PHARMACEUTICALS, INC. 2003-02-25 US disclosed
EP-1109560-A4 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMA (US) 2002-04-17 EP disclosed
EP-1109560-A1 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMACEUTICALS, INC. (US) 2001-06-27 EP disclosed
WO-2000013688-A1 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMACEUTICALS, INC. (US) 2000-03-16 WO disclosed